194 related articles for article (PubMed ID: 7669872)
1. [Influence of glycemic blood glucose control and incipient diabetic nephropathy on the urinary excretion of N-acetyl-glucosaminidase (NAG) in diabetes mellitus].
Sánchez-Hueso MC; Mateo-Caãs J; Zamora-Madaria E
An Med Interna; 1995 May; 12(5):216-20. PubMed ID: 7669872
[TBL] [Abstract][Full Text] [Related]
2. Urinary excretion of beta-thromboglobulin and N-acetyl-beta-D-glucosaminidase in type 1 diabetes: potential indicators of early nephropathy?
Patrick AW; Oliver MD; Howie AF; Dawes J; Macintyre CC; Frier BM
Diabete Metab; 1990; 16(5):441-7. PubMed ID: 2150050
[TBL] [Abstract][Full Text] [Related]
3. Melatonin reduces urinary excretion of N-acetyl-beta-D-glucosaminidase, albumin and renal oxidative markers in diabetic rats.
Oktem F; Ozguner F; Yilmaz HR; Uz E; Dündar B
Clin Exp Pharmacol Physiol; 2006; 33(1-2):95-101. PubMed ID: 16445706
[TBL] [Abstract][Full Text] [Related]
4. Urinary N-acetyl-beta-D-glucosaminidase activity in type I diabetes mellitus.
Mungan N; Yuksel B; Bakman M; Topaloglu AK; Ozer G
Indian Pediatr; 2003 May; 40(5):410-4. PubMed ID: 12768043
[TBL] [Abstract][Full Text] [Related]
5. Urinary beta 2-microglobulin levels and urinary N-acetyl-beta-D-glucosaminidase enzyme activities in early diagnosis of non-insulin-dependent diabetes mellitus nephropathy.
Mocan Z; Erem C; Yildirim M; Telatar M; Değer O
Diabetes Res; 1994; 26(3):101-7. PubMed ID: 7621616
[TBL] [Abstract][Full Text] [Related]
6. Urinary activities of cathepsin B, N-acetyl-beta-D-glucosaminidase, and albuminuria in patients with type 2 diabetes mellitus.
Piwowar A; Knapik-Kordecka M; Fus I; Warwas M
Med Sci Monit; 2006 May; 12(5):CR210-4. PubMed ID: 16641878
[TBL] [Abstract][Full Text] [Related]
7. Plasma and urinary vascular endothelial growth factor and diabetic nephropathy in Type 2 diabetes mellitus.
Kim NH; Kim KB; Kim DL; Kim SG; Choi KM; Baik SH; Choi DS; Kang YS; Han SY; Han KH; Ji YH; Cha DR
Diabet Med; 2004 Jun; 21(6):545-51. PubMed ID: 15154937
[TBL] [Abstract][Full Text] [Related]
8. Contribution of glycemic control to the levels of urinary N-acetyl-beta-D-glucosaminidase (NAG), total protein, beta 2-microglobulin and serum NAG in type 1 (insulin-dependent) diabetes mellitus without macroalbuminuria.
Watanabe Y; Nunoi K; Maki Y; Nakamura Y; Fujishima M
Clin Nephrol; 1987 Nov; 28(5):227-31. PubMed ID: 3322619
[TBL] [Abstract][Full Text] [Related]
9. [Urinary glycosaminoglycans in patients with incipient diabetic nephropathy].
Ueta I; Takamatsu K; Hashimoto K
Nihon Jinzo Gakkai Shi; 1995 Jan; 37(1):17-23. PubMed ID: 7699949
[TBL] [Abstract][Full Text] [Related]
10. [Clinical evaluation of N-acetyl-beta-D-glucosaminidase on prediction of diabetic nephropathy].
Minakami H
Hokkaido Igaku Zasshi; 1992 Mar; 67(2):234-46. PubMed ID: 1350771
[TBL] [Abstract][Full Text] [Related]
11. The significance of urinary N-acetyl-beta-D-glucosaminidase for predicting early stage diabetic nephropathy.
Kato H; Takashima T; Kishikawa H; Emura S; Ohmori K
Int J Clin Pract; 1997; 51(8):489-90. PubMed ID: 9536599
[TBL] [Abstract][Full Text] [Related]
12. Measurement of urinary N-acetyl-b-D-glucosaminidase in adult patients with cystic fibrosis: before, during and after treatment with intravenous antibiotics.
Etherington C; Bosomworth M; Clifton I; Peckham DG; Conway SP
J Cyst Fibros; 2007 Jan; 6(1):67-73. PubMed ID: 16844430
[TBL] [Abstract][Full Text] [Related]
13. Urinary excretion of n-acetyl-beta-D-glucosaminidase and retinol binding protein as alternative indicators of nephropathy in patients with type 1 diabetes mellitus.
Salem MA; el-Habashy SA; Saeid OM; el-Tawil MM; Tawfik PH
Pediatr Diabetes; 2002 Mar; 3(1):37-41. PubMed ID: 15016173
[TBL] [Abstract][Full Text] [Related]
14. [Urinary proteins in patients with diabetes mellitus].
Hofmann W; Guder WG
Klin Wochenschr; 1989; 67 Suppl 17():37-9. PubMed ID: 2472508
[TBL] [Abstract][Full Text] [Related]
15. Infusion of radiocontrast agents induces exaggerated release of urinary endothelin in patients with impaired renal function.
Fujisaki K; Kubo M; Masuda K; Tokumoto M; Hirakawa M; Ikeda H; Matsui R; Matsuo D; Fukuda K; Kanai H; Hirakata H; Iida M
Clin Exp Nephrol; 2003 Dec; 7(4):279-83. PubMed ID: 14712357
[TBL] [Abstract][Full Text] [Related]
16. [Serum N-acetyl-beta-D-glucosaminidase (NAG) activity in patients with diabetes mellitus with reference to diabetic microangiopathy].
Gosiewska A; Kinalska I; Zarzycki W; Górska M; Borejszo I
Pol Tyg Lek; 1992 Jan 6-13; 47(1-2):28-30. PubMed ID: 1409037
[TBL] [Abstract][Full Text] [Related]
17. Comparative effect of lisinopril and lacidipine on urinary albumin excretion in patients with type 11 diabetic nephropathy.
Salako BL; Finomo FO; Kadiri S; Arije A; Olatosin AO
Afr J Med Med Sci; 2002 Mar; 31(1):53-7. PubMed ID: 12518931
[TBL] [Abstract][Full Text] [Related]
18. Blood levels of total homocysteine in patients with type 1 diabetes (with no complications, diabetic nephropathy and/or retinopathy) and in their non-diabetic relatives.
Matteucci E; Rossi L; Mariani S; Fagnani F; Quilici S; Cinapri V; Giampietro O
Nutr Metab Cardiovasc Dis; 2002 Aug; 12(4):184-9. PubMed ID: 12514938
[TBL] [Abstract][Full Text] [Related]
19. Uric acid excretion and dopamine-induced glomerular filtration response in patients with IgA glomerulonephritis.
Sulikowska B; Manitius J; Odrowaz-Sypniewska G; Łysiak-Szydłowska W; Rutkowski B
Am J Nephrol; 2008; 28(3):391-6. PubMed ID: 18063857
[TBL] [Abstract][Full Text] [Related]
20. [Determination of N-acetyl-glucosaminidase (NAG) in diabetic subjects].
Melosi A; Ricci F
Quad Sclavo Diagn; 1983 Mar; 19(1):113-20. PubMed ID: 6675040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]